Page 24 - Pharma Industry

Biotech cos Tzar Labs and Epigeneres to launch early-detection cancer tests

Firms claim breakthrough with their RNA-marker tech which detects cancer even in stage zero

Pharma sector's Q4 results show moderate gains amid Covid-19 pandemic

The ongoing April-June quarter should see strong growth due to low base of last year

Cipla open to forge a partnership to distribute Covid-19 vaccines in India

The company already makes and markets antiviral drugs like remdesivir, favipiravir in India apart from importing and distributing Roche's tocilizumab (Actemra)

Alembic Pharma Q4 net up 12% to Rs 251 cr on strong API, global businesses

Net sales rise 6% to Rs 1,280 cr; API business expands by as much as 38%

State govts begin vaccine price negotiations, eye Rs 150 per dose

States would have to fund procurement from their own budgets and bridge funding from the Centre is unlikely

Pharma poised for an excellent FY22 on the back of Covid-led demand

Improving exports and a weak rupee could support profit boost

Strong injectables portfolio to support Aurobindo Pharma's growth

The stock has been underperforming recent months and trades at a discount to peers

Shortage of key chemical hits Bharat Biotech's Covaxin ramp-up plans

Bharat Biotech is trying to ramp up capacities of Covaxin to 12 million doses per month by July, from the current 5 million doses per month

Alembic Pharma's injectables plant launch may face some delay

Company saw Form 483 with observations issued by US FDA for injectables plant in February

Piramal Pharma to acquire 100% stake in Hemmo Pharma for Rs 775 cr

Consequent to the acquisition, Hemmo Pharmaceuticals Pvt Ltd would become a wholly-owned subsidiary of Piramal Pharma Ltd

Orchid Pharma rises from ashes, expects to make profits in 12 months

Dhanuka Pharmaceuticals that took over the company almost a year ago, nursed it back to health from bankruptcy

Govt okays 33 API applications with Rs 5k cr investment under PLI scheme

In total, 215 applications have been received for the 36 products spread across the 4 target segments, the Ministry of Chemicals and Fertilizers said in the release

New launches, market share gains to sustain Gland Pharma's sales trajectory

Earnings are expected to grow over 25 per cent over the next two years

Healing a weak regulator

Weaknesses in India's drug regulatory regime and the constraints and questionable decisions of the drug regulator could mar the country's reputation in global markets

Pharma stocks may hold ground as volatility grips global markets

The Nifty Pharma index was down 1.76 per cent on Friday compared to a 568-point or nearly 3.8 per cent slide in the Nifty50 on weak global cues

Make next 10 years 'the decade of India': Piyush Goyal to pharma firms

Coining a new acronym, Goyal said the world today needs CURE - Cost-effective Uni­ve­rsal solutions through Research and Enterprise

Weak Q3 show, margin pressures to keep Sanofi stock under pressure

Growth led by power brands and new launches could recover as pandemic impact wanes

PLI scheme: Pharma industry expects more guidelines on investment

B R Sikri, chairman of the Federation of Pharma Entrepreneurs, said, higher incentives would have meant more production of cancer drugs, thereby, bringing down their prices

Centre announces Rs 15,000 crore PLI for pharma, IT hardware sectors

Pharma scheme aims at Rs 3 trillion incremental sales, 100,000 jobs; experts say hardware scheme to help India become electronics manufacturing hub for the world

Asset monetisation, sales uptick in US key triggers for Glenmark Pharma

The India business is expected to post double digit growth in FY22